Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 24kWORD 21k
11 June 2019
Answer given by Mr Andriukaitis on behalf of the European Commission
Question reference: E-001796/2019

The production and adaptation of Clinical Practice Guidelines and other Clinical Decision Support Tools is one of the key objectives of the European Reference Networks (ERN) system established under the directive on the application of patients’ rights in cross-border healthcare(1).

The ERN Delegated Decision(2) establishes that Networks shall develop and implement clinical guidelines and cross-border patient pathways and that the healthcare providers applying to become members of the Networks must develop and use clinical guidelines and pathways in their area of expertise. The Commission is supporting the ERNs in developing the guidelines through actions financed by the EU Health programme including the development of a common methodology, training and capacity building and technical support to the current 24 ERNs. This aim is to develop or adapt in the next three years more than 100 clinical practices guidelines and other decision support making tools.

Complementary initiatives with Member States in the area of rare diseases may also be discussed in the context of the Steering Group on Health Promotion, Disease Prevention and Management of Non-Communicable Diseases(3).


Last updated: 13 June 2019Legal notice